BDBM673757 (1r,4S,8′S)-4-(3-chloroanilino)-8′-[(2R)-2-methyl-3-{[(5R)-5-methyl-5,6,7,8-tetrahydroquinolin-4-yl]oxy}propyl]-3′-(propan-2-yl)-3′,4′,8′,9′-tetrahydro-2′H-spiro[cyclohexane-1,7′-indeno[5,6-b][1,4]dioxepine]-4-carboxylic acid, diastereoisomer 2::US20240150293, Example 993

SMILES CC(C)[C@H]1COc2cc3c(cc2OC1)[C@]1(CC[C@@](Nc2cccc(Cl)c2)(C(=O)O)CC1)[C@@H](C[C@@H](C)COc1ccnc2c1[C@H](C)CCC2)C3

InChI Key InChIKey=FNYZRTFWODISJB-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 673757   

TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Human)
Les Laboratoires Servier

US Patent
LigandChemical structure of BindingDB Monomer ID 673757BDBM673757(US20240150293, Example 993 | (1r,4S,8′S)-4-(...)
Affinity DataKi:  0.0670nMAssay Description:The addition of a compound which binds competitively to the same site as the peptide will result in an increase in the fluorescence intensity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2024
Entry Details
US Patent